Orthogonal's experience with SaMD enables them to rapidly develop, launch, and continuously improve connected, compliant products. They offer this innovative approach to clients, assisting them in building their own SaMD product development workflows. Over the last decade, they have collaborated with partners ranging from startups to Fortune 500 firms in the highly regulated space of medical devices, diagnostics, and pharmaceuticals. However, no specific recent investment details are available for Orthogonal.
Orthogonal
Accelerating SaMD Development to Improve Patient Lives | ISO 13485 & HIPAA Certified | Class I-III Device Experts
Founded 1998
Chicago, United States
63 employees
Health Care, Medical Devices +1
Chicago, United States
63 employees
Health Care, Medical Devices +1
General Information
Company Name
Orthogonal
Founded Year
1998
Location
Chicago, United States
Chicago, United States
Founders / Decision Makers
Employees
63
Industries
Health Care, Medical Devices, Mobile
Social
BounceWatch is an independent company data service, not affiliated with Orthogonal. To contact Orthogonal, visit orthogonal.io.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Orthogonal compare?
A PDF of Orthogonal and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Orthogonal soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Orthogonal on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Health Care
About Orthogonal
Business keywords: Software as a Medical Device, Digital Therapeutics, Medical Software Development, Healthcare Data Analytics, User Experience Design, Agile Software Development, FDA Compliance, EU Compliance, Connected Medical Devices, Patient Engagement & Analytics, Data Visualization, Mobile Application Development
No funding data available for Orthogonal yet.
Orthogonal Alternatives & Competitors
View All Alternatives
Orthogonal vs
moveUP - digital therapies
Belgium
Follow us to stay updated on our findings on value-based health care derived from our growing set of...
Merged
26 employees
Biotechnology, Digital Health
Orthogonal vs
LifeTime
Germany
Digitaler Austausch von Befunden, Dokumenten und Bildern für Ärzte und Patienten - einfach und daten...
Venture round
5 employees
Developer Tools, Health Care
Orthogonal vs
Tenovi, an Inc. 5000 Company
United States
Improving lives by simplifying remote care | Inc. 5000 #55 in the US, #2 in Boston Metro, #1 in NH a...
Series A
44 employees
Health Care, Information Technology
FAQ About Orthogonal
Accelerating SaMD Development to Improve Patient Lives | ISO 13485 & HIPAA Certified | Class I-III Device Experts
Orthogonal was founded in 1998.
Orthogonal is headquartered in Chicago, United States.
Orthogonal operates in Health Care, Medical Devices and Mobile. Its work centres on Software as a Medical Device, Digital Therapeutics, Medical Software Development and Healthcare Data Analytics.
Orthogonal has approximately 63 employees.
Top alternatives and competitors to Orthogonal include moveUP - digital therapies, LifeTime, Tenovi, an Inc. 5000 Company, CriTech Research, Inc., MobileODT. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orthogonal and moveUP - digital therapies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Orthogonal, https://bouncewatch.com/company/orthogonal, updated 29 November 2024. When citing, please name BounceWatch and link this page.
